share_log

Pfizer | 3: Initial statement of beneficial ownership of securities-Officer Baum Andrew

Pfizer | 3: Initial statement of beneficial ownership of securities-Officer Baum Andrew

辉瑞 | 3:首次持股声明-高管 Baum Andrew
美股sec公告 ·  08/02 09:54
Moomoo AI 已提取核心信息
Pfizer Executive Vice President Andrew Baum filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated August 1, 2024, indicates that Baum does not beneficially own any Pfizer securities. The document, which is a standard disclosure for insiders of publicly traded companies, was signed by Baum's attorney, Susan E. Grant, on August 2, 2024. This filing is in compliance with Section 16(a) of the Securities Exchange Act of 1934 and is a routine procedure for executives and directors to report their stock holdings in the company.
Pfizer Executive Vice President Andrew Baum filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated August 1, 2024, indicates that Baum does not beneficially own any Pfizer securities. The document, which is a standard disclosure for insiders of publicly traded companies, was signed by Baum's attorney, Susan E. Grant, on August 2, 2024. This filing is in compliance with Section 16(a) of the Securities Exchange Act of 1934 and is a routine procedure for executives and directors to report their stock holdings in the company.
辉瑞总裁Andrew Baum根据3号表格规定向美国证券交易委员会提交了证券的初始有益所有权声明。该文件是公开交易公司内部人士标准披露文件,填表日期为2024年8月1日,表明Baum没有持有任何辉瑞证券的有益所有权。该文件由Baum的律师Susan E. Grant于2024年8月2日签署。该申报遵守1934年证券交易法的16(a)条款,并且是高管和董事报告公司股票持有情况的例行程序。
辉瑞总裁Andrew Baum根据3号表格规定向美国证券交易委员会提交了证券的初始有益所有权声明。该文件是公开交易公司内部人士标准披露文件,填表日期为2024年8月1日,表明Baum没有持有任何辉瑞证券的有益所有权。该文件由Baum的律师Susan E. Grant于2024年8月2日签署。该申报遵守1934年证券交易法的16(a)条款,并且是高管和董事报告公司股票持有情况的例行程序。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息